Brief: Merck Healthcare Reports 8.3% Passive Stake In Moonlake Immunotherapeutics
03/08/2022 12:23
Aug 3 (Reuters) - Merck Healthcare:
* MERCK HEALTHCARE KGAA REPORTS 8.3% PASSIVE STAKE IN
MOONLAKE
IMMUNOTHERAPEUTICS AS OF AUGUST 6 - SEC FILING
Further company coverage: MLTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MoonLake Immunotherapeutics
See all newsMoonLake jumps as AbbVie's weak skin drug data eases competition fears
Brief: Moonlake Immunotherapeutics Files For Mixed Shelf Offering, Size Not Disclosed
MoonLake Immunotherapeutics reports results for the quarter ended June 30 - Earnings Summary
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial (updated)
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial